National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

daniquidone
A water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA replication and repair, and RNA and protein synthesis. The acetylated form of daniquidone is highly toxic and is capable of inducing unscheduled DNA synthesis; rapid acetylators are more likely to experience toxicity with this agent. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:batracylin
Chemical structure name:8-aminoisoindolo(1,2-b)quinazolin-12(10H)-one



Previous:daclizumab, Dacogen, dactinomycin, dalteparin, danazol
Next:Danocrine, daptomycin, Daraprim, darbepoetin alfa, darinaparsin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov